Edmond de Rothschild Holding’s Ocular Therapeutix OCUL Stock Holding History

Edmond de Rothschild Holding’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-65,000	Closed	-$402K	–	824
2017 Q3	$402K	Buy	65,000 +15,000	+30%	+$96.6K	0.01%	392
2017 Q2	$463K	Sell	50,000 -20,000	-29%	-$194K	0.01%	390
2017 Q1	$650K	Hold	70,000	–	–	0.02%	339
2016 Q4	$586K	Hold	70,000	–	–	0.02%	347
2016 Q3	$481K	Hold	70,000	–	–	0.01%	382
2016 Q2	$346K	Buy	70,000 +25,000	+56%	+$248K	0.01%	428
2016 Q1	$435K	Hold	45,000	–	–	0.01%	386
2015 Q4	$422K	Buy	45,000 +18,000	+67%	+$194K	0.01%	395
2015 Q3	$380K	Buy	+27,000	New	+$543K	0.01%	377

Other funds holding OCUL

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Edmond de Rothschild Holding's OCUL Position: Q4 2017 in Review

Edmond de Rothschild Holding sold out of Ocular Therapeutix (OCUL) in Q4 2017, closing a stake of 65,000 shares — an estimated $402K sold.

Edmond de Rothschild Holding first reported a position in OCUL in Q3 2015 and held it in 9 quarters. The position peaked at $650K in Q1 2017. 69 funds tracked by Wall St. Rank hold OCUL as of Q4 2017.

Edmond de Rothschild Holding reported no remaining Ocular Therapeutix position as of Q4 2017 after selling out during the quarter.
Edmond de Rothschild Holding sold 65,000 Ocular Therapeutix shares in Q4 2017, an estimated $402K.
Edmond de Rothschild Holding first reported a position in Ocular Therapeutix in Q3 2015 and held it in 9 quarters.
Edmond de Rothschild Holding's Ocular Therapeutix position peaked at $650K in Q1 2017.
69 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q4 2017.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2017, filed 14 Feb 2018.